Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

PLC-gamma 1 (p Tyr783) Mouse anti-Human, DyLight 680, Clone: MM0870-47Q33, Novus Biologicals™

Mouse Monoclonal Antibody

Manufacturer:  Novus BiologicalsSupplier Diversity Partner NBP236791FR

Catalog No. NBP236791FR

Add to cart



PLC-gamma 1 p Tyr783 Monoclonal antibody specifically detects PLC-gamma 1 p Tyr783 in Human samples. It is validated for Western Blot.


PLC-gamma 1 (p Tyr783)
Western Blot
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells) from a mouse immunized with Phosphopeptide containing Y783 of human PLC gamma -1.
Protein G purified
Lipid and Metabolism, Phospho Specific, Signal Transduction
Western Blot
DyLight 680
50mM Sodium Borate with 0.05% Sodium Azide
EC, gamma 1 (formerly subtype 148), monophosphatidylinositol phosphodiesterase, NCKAP3,1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1, phosphatidylinositol phospholipase C, phosphoinositidase C, phosphoinositide phospholipase C, Phosphoinositide phospholipase C-gamma-1, phospholipase C, gamma 1, phospholipase C-148, Phospholipase C-gamma-1, Phospholipase C-II, PLC11-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 1, PLC148, PLC-148, PLC-gamma-1, PLC-II1-phosphatidyl-D-myo-inositol-4,5-bisphosphate, triphosphoinositide phosphodiesterase
0.1 ml
Store at 4C in the dark.
This antibody recognizes human PLC gamma-1 of pY783 in direct ELISAs and WBs.
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit